Micropeptide MIAC inhibits the tumor progression by interacting with AQP2 and inhibiting EREG/EGFR signaling in renal cell carcinoma

Micropeptide MIAC inhibits the tumor progression by interacting with AQP2 and inhibiting EREG/EGFR signaling in renal cell carcinoma

Abstract Background Although, micropeptides encoded by non-coding RNA have been shown to have an important role in a variety of tumors processes, there have been no reports on micropeptide in renal cell carcinoma (RCC). Based on the micropeptide MIAC (micropeptide inhibiting actin cytoskeleton) disc...

Full description

Bibliographic Details
Main Authors: Mengwei Li, Guangxiang Liu, Xinrong Jin, Hongqian Guo, Sarra Setrerrahmane, Xindi Xu, Tiantian Li, Yunfei Lin, Hanmei Xu
Format: Article
Language:English
Published: BMC 2022-09-01
Series:Molecular Cancer
Subjects:
Non-coding RNA
Micropeptides
Renal cell carcinoma
MIAC
Aquaporin 2
EREG/EGFR pathway
Online Access:https://doi.org/10.1186/s12943-022-01654-1

Internet

https://doi.org/10.1186/s12943-022-01654-1

Similar Items